GALT NASDAQ
Galectin Therapeutics Inc.
1W: +0.0%
1M: -12.9%
3M: -15.8%
YTD: -3.7%
1Y: -6.7%
3Y: +115.5%
5Y: -6.0%
$3.90
+0.14 (+3.72%)
Weekly Expected Move ±8.1%
$3
$4
$4
$4
$5
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-28M
Net Income
+31.0% YoY
$-16M
Free Cash Flow
+55.4% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE21.9%
ROA-183.0%
ROIC99.4%
Valuation
P/E-9.1
P/B-1.9
EV/EBITDA-31.3
Leverage
Debt/Equity-1.01
Current Ratio0.10
Interest Cov.-1.8x
Quality Scores
Piotroski F2/9
Altman Z-55.14
Beneish M0.00